Pharmafile Logo
Pharmafocus logo
Advanced Search
Eisai's new European HQ in Hatfield, Hertfordshire

Eisai opens new European HQ in the UK

July 8, 2009
Manufacturing and Production, Research and Development, Sales and Marketing Eisai, Europe, HQ

Eisai has officially opened its new European headquarters in the UK, its biggest-ever single capital investment that will bring teams …

Feature
UCB's new biologics research centre in Slough

UCB opens new UK biologics research centre

July 8, 2009
Research and Development UCB

 UCB has officially opened its new biologics research centre in the UK, representing an investment of £25 million for the …

News

GMP violations at Indian CMO hit UK generics makers

July 8, 2009
Manufacturing and Production Asia, India

Eight manufacturers of generic medicines in the UK have been forced to withdraw batches of product from the market because …

News

Sanofi moves to quell Lantus safety concerns

July 7, 2009
Research and Development, Sales and Marketing Lantis, Sanofi-Aventis, diabetes

Sanofi-Aventis has rejected claims of a possible connection between its diabetes treatment Lantus and cancer. The possible link was reported …

News

Depression warnings for Chantix and Zyban

July 7, 2009
Research and Development, Sales and Marketing Chantix, FDA, US, drug safety

Pfizer and GSK's smoking cessations drugs will have to carry strong warnings of depression and other mental health adverse events …

News

PM Soc’s Digital Media Awards to highlight pioneering work

July 7, 2009
Sales and Marketing digi, pm society

UK pharma companies and agencies are being invited to submit entries to the industry's first-ever digital media awards, which aim …

News
VasellaWEB

Vasella: on leadership

July 7, 2009
Sales and Marketing Novartis, Vasella, leadership, management

Novartis’ chief executive and chairman talks to McKinsey about his personal approach to management and leadership, and examines subjects including …

Feature

Pharmaceutical manufacturing: news in brief

July 6, 2009
Manufacturing and Production Genzyme, Quotient

Pharmafocus presents a round-up of developments in manufacturing, including facility updates from Genzyme, Caraco, MSD, Rottapharm and Almac Pharma Services, …

News

NHS expectations ‘artificially inflated’

July 6, 2009
NHS, healthcare

Expectations of what the NHS can deliver may be artificially inflated by the government's latest grand plan, according to the …

News

Novasep buys Henogen to get ‘bigger in bio’

July 6, 2009
Manufacturing and Production Novasep

French contract manufacturing firm Novasep has acquired a Belgian company, Henogen, in order to expand the range of biologic drugs …

News

Roche’s ABPI exit – a deliberate snub?

July 3, 2009
Research and Development, Sales and Marketing ABPI, Roche

 By Nicola O’BrienRoche is yet to explain its controversial exit from the ABPI, but the company seems determined to make …

News

Euro RSCG buys Medicom

July 3, 2009
Medical Communications Euro RSCG, advertising

Euro RSCG Life, one of healthcare's largest communications groups, has acquired the London-based Medicom Group. The medical communications agency is …

News

HRA Pharma opens UK subsidiary

July 3, 2009
Sales and Marketing HRA Pharma

Privately-owned French drug maker HRA Pharma, which specialises in reproductive health and endocrinology, has opened its first UK subsidiary. The …

News

Asia Pacific vaccines market requires flexible, targeted portfolios

July 2, 2009
Research and Development, Sales and Marketing Asia, vaccines

Spanning one third of the globe's circumference and home to more than half of the world's population, the Asia Pacific …

News

Onglyza and Cimzia recommended by CHMP

July 2, 2009
Research and Development, Sales and Marketing AZ, BMS, EMEA, Europe, Ongylza

Bristol-Myers Squibb andAstraZeneca's type II diabetes treatment Onglyza is among the brands to have received positive opinions from the Committee …

News

Pfizer halts Sutent colon cancer trial

July 2, 2009
Research and Development, Sales and Marketing Cancer, Pfizer, Sutent

Pfizer has halted a phase III trial for its oncology hope Sutent, after it failed to show significant improvement in …

News

Coaching your team through testing times

July 2, 2009
Business Services coaching, recruitment

A fundamental aim of coaching is to raise our self-awareness, reconnect us with our choices at work and build self-confidence. …

Feature

Rovi wins Spanish contract for flu vaccines

July 1, 2009
Manufacturing and Production, Research and Development Europe, Rovi, Spain

News

Lonza spat with Altus over manufacturing deal escalates

July 1, 2009
Manufacturing and Production Lonza

Altus Therapeutics has officially called a halt to a supply agreement with contract manufacturer Lonza in the latest round of …

News

Sanofi unveils new R&D strategy

July 1, 2009
Research and Development, Sales and Marketing Sanofi-Aventis

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026